Therapeutic derivatives of interleukin-22
US11806403B2 · kind B2 · utility
0Cited by
1References
96Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 5, 2022 |
| Grant date | Nov 7, 2023 |
| Priority date | — |
| Expiry date | May 5, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to novel derivatives of Interleukin-22 (IL-22), particularly those comprising a fatty acid covalently attached to an IL-22 protein, and their use in therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.